Ursodeoxycholic Acid clinical trials
Also written Ursodiol and Urso.
How each study uses Ursodeoxycholic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Ursodeoxycholic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 31 Dec 1987 · ACTIGALL · NDA 019594 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
97 studies that test it; most in 2026 (9)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1995 | 1 |
| 1998 | 1 |
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 1 |
| 2026 | 9 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 14 · Other 83
Daewoong Pharmaceutical Co. LTD. (7) · Tanta University (4) · Institute of Liver and Biliary Sciences, India (2) · Teva Pharmaceuticals USA (2) · Radboud University Medical Center (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Dr. Falk Pharma GmbH (2) · Jinling Hospital, China (2)
Often tested with
Tested in the same studies.
Pentoxifylline (3) · Thiamine (2) · Sitagliptin (2) · Fenofibrate (2) · Omega-3 fatty acid (1) · Phototherapy (1) · Zinc Sulfate (1) · Nirmatrelvir and ritonavir drug combination (1)
Related medicines
As reviewed, each with the page that says it.
- One of Protein Kinase Inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 2 phase 3 studies under way
Ursodeoxycholic Acid is the comparator. A study of two new drugs counts under both.
- 1Fenofibrate · Xijing Hospital of Digestive Diseases · next primary completion Dec 2028
Reaching primary completion within a year · 8, 3 in phase 3
Studies that test Ursodeoxycholic Acid, phase 3 first.
- May 2027Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment SurgeryPhase 3 · Hopital Foch
- Jul 2027Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute PancreatitisPhase 3 · Hospital General Universitario de Alicante
- Oct 2027Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With SepsisPhase 2/3 · Tanta University
- Nov 2026Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose ToleranceNot applicable · First Affiliated Hospital Xi'an Jiaotong University
- Dec 2026Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal TumorsPhase 2 · Jinling Hospital, China
- Jan 2027The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect HyperbilirubinemiaNot applicable · Tishreen University Hospital
- Jun 2027UDCA to Prevent Post-TIPS Hepatic EncephalopathyNot applicable · West China Hospital
- Nov 2027Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients.Not applicable · Institute of Liver and Biliary Sciences, India
Studies
Open first, then newest update. How each study uses Ursodeoxycholic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 97
- Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard TherapyRecruitingEarly Phase 1Medical College of WisconsinNCT06884748Written as Ursodiol 500 MGHow we know
- Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal TumorsRecruitingPhase 2Jinling Hospital, ChinaNCT07672860Written as UDCA (Ursodeoxycholic acid)How we know
- Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With SepsisNot yet recruitingPhase 2/3Tanta UniversityNCT07852780Written as Ursodeoxycholic AcidHow we know
- Comparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic HepatitisRecruitingPhase 2University Hospital, MontpellierNCT07378761Written as UDCA (Ursodeoxycholic acid)How we know
- Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder CancerRecruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07717242Written as Ursodeoxycholic AcidHow we know
- Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose ToleranceRecruitingNot applicableFirst Affiliated Hospital Xi'an Jiaotong UniversityNCT06684106Written as Ursodeoxycholic acid (UDCA) 500 mgHow we know
- Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients.Not yet recruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT07664020Written as Ursodeoxycholic acidHow we know
- The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect HyperbilirubinemiaRecruitingNot applicableTishreen University HospitalNCT07110987Written as ursodeoxycholic acid (UDCA)How we know
- Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral HepatitisNot yet recruitingNot applicableCombined Military Hospital, PakistanNCT07525401Written as Ursodeoxycholic AcidHow we know
- Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary CholangitisRecruitingPhase 3Xijing Hospital of Digestive DiseasesNCT05751967Written as Fenofibrate Combined With Ursodeoxycholic AcidHow we know
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World StudyRecruitingPhase 3Xijing Hospital of Digestive DiseasesNCT06755541Written as Fenofibrate in Combination With Ursodeoxycholic AcidHow we know
- UDCA to Prevent Post-TIPS Hepatic EncephalopathyNot yet recruitingNot applicableWest China HospitalNCT07273734Written as Ursodeoxycholic Acid (UDCA)How we know
- Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal MetaplasiaRecruitingPhase 4Yongquan ShiNCT06610760Written as Ursodeoxycholic AcidHow we know
- Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment SurgeryRecruitingPhase 3Hopital FochNCT06294847Written as UrsolvanHow we know
- Clinical Research of Tapering UDCA in PBC Patients With a Complete ResponseRecruitingPhase 4Peking Union Medical College HospitalNCT04650243Written as ursodeoxycholic acidHow we know
- Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute PancreatitisRecruitingPhase 3Hospital General Universitario de AlicanteNCT04924868Written as Ursodeoxycholic AcidHow we know
- Ursodeoxycholic Acid as add-on Therapy in Type 2 Diabetes MellitusRecruitingPhase 2/3Tanta UniversityNCT05902468Written as Ursodeoxycholic acidHow we know
- A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-InfectionNot yet recruitingPhase 2National Taiwan University HospitalNCT05467553Written as Ursodeoxycholic acidHow we know
- Ursodeoxycholic Acid vs Metformin in Gestational Diabetes MellitusTerminatedPhase 4King's College LondonNCT04407650Written as Ursodeoxycholic AcidHow we know
- Effect of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates Treated With PhototherapyCompletedNot applicableMuhammad Aamir LatifNCT07867366Written as Phototherapy with ursodeoxycholic acidHow we know
See all 97 studies that test Ursodeoxycholic Acid →
Given beside what is tested · 24 — Ursodeoxycholic Acid is usual care or a partner of the new treatment
- Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic AcidRecruitingPhase 3Xijing Hospital of Digestive DiseasesNCT02823366Written as UDCAHow we know
- Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)RecruitingPhase 2/3Xijing Hospital of Digestive DiseasesNCT06365424Written as UDCAHow we know
- Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary CholangitisRecruitingPhase 2/3Xijing Hospital of Digestive DiseasesNCT05749822Written as UDCAHow we know
- Glucocorticoids for Acute Drug Induced Liver Injury With HyperbilirubinemiaRecruitingNot applicableGeneral Hospital of Shenyang Military RegionNCT06922669Written as Ursodeoxycholic acid capsulesHow we know
- PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast CancerNot yet recruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT06842472Written as Ursodeoxycholic Acid (URSO)How we know
- Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related HepatitisRecruitingPhase 2Inge Marie SvaneNCT04810156Written as Ursodeoxycholic acidHow we know
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CholangitisActive, not recruitingPhase 2/3Han YingNCT06174402Written as UDCAHow we know
- Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary CirrhosisCompletedPhase 3Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.NCT06715319Written as UDCAHow we know
- Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary CholangitisCompletedPhase 3Nanjing Chia-tai Tianqing PharmaceuticalNCT05450887Written as UDCAHow we know
- Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)TerminatedPhase 2Intercept PharmaceuticalsNCT00550862Written as Ursodeoxycholic Acid (URSO)How we know
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisCompletedPhase 3Xijing Hospital of Digestive DiseasesNCT02823353Written as UDCAHow we know
- Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCAWithdrawnPhase 1/2Beijing 302 HospitalNCT02965911Written as UDCAHow we know
- Study of Obeticholic Acid(OCA) Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)Status unknownPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT04956328Written as UDCAHow we know
- A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary CholangitisStatus unknownPhase 3Instituto Mexicano del Seguro SocialNCT04751188Written as Ursodeoxycholic AcidHow we know
- Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary CholangitisCompletedNot applicableNational Scientific Medical Center, KazakhstanNCT03665519Written as Ursodeoxycholic AcidHow we know
- Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary CirrhosisCompletedPhase 2Mirum Pharmaceuticals, Inc.NCT01904058Written as Ursodeoxycholic AcidHow we know
- Fibrates in Pediatric CholestasisCompletedPhase 2Hoda A. AttaNCT03586674Written as UrsogalHow we know
- Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing CholangitisStatus unknownPhase 1/2Fuzhou General HospitalNCT03516006Written as UDCAHow we know
- Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-respondersStatus unknownPhase 3Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranNCT02937012Written as Ursodeoxycholic AcidHow we know
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of PruritusCompletedPhase 2GlaxoSmithKlineNCT01899703Written as Ursodeoxycholic acidHow we know
Showing 20 of 24.
As the comparator · 14 — what is tested is compared with Ursodeoxycholic Acid
- FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC TherapyRecruitingPhase 3Xijing Hospital of Digestive DiseasesNCT07296458Written as UDCA (Ursodeoxycholic acid)How we know
- A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis CharacteristicsEnrolling by invitationPhase 2/3Han YingNCT06591468Written as UDCA (Ursodeoxycholic acid)How we know
- Gepaktiv vs UDCA and Ademetionine in MAFLD With HepatomegalyRecruitingNot applicablePhenomen PharmaNCT07068191Written as UDCA (Ursodeoxycholic acid)How we know
- A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)WithdrawnPhase 2HighTide Therapeutics (Hong Kong) LimitedNCT03678480Written as Ursodeoxycholic AcidHow we know
- A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary CholangitisCompletedEarly Phase 1Han YingNCT06591455Written as UDCA (Ursodeoxycholic acid)How we know
- Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease PatientsStatus unknownPhase 4MinaPharm PharmaceuticalsNCT05849558Written as UDCA 250mgHow we know
- Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap SyndromeStatus unknownNot applicableXiaoli FanNCT02936596Written as Ursodeoxycholic AcidHow we know
- Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features IIStatus unknownPhase 4West China HospitalNCT04617561Written as Ursodeoxycholic acidHow we know
- Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic SteatohepatitisCompletedNot applicableMedical Centre Hospital of the President's Affairs Administration, Republic of KazakhstanNCT03664596Written as Ursodeoxycholic AcidHow we know
- Probiotics for Gallstones in Post-bariatric Surgery Patients:A Prospective Randomized TrialStatus unknownNot applicableMin-Sheng General HospitalNCT03247101Written as Urso groupHow we know
- Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in InfantsWithdrawnPhase 2The University of Texas Health Science Center at San AntonioNCT02420496Written as Ursodeoxycholic AcidHow we know
- Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBCCompletedPhase 3Beijing Trendful Kangjian Medical Information Consulting Limited CompanyNCT01829698Written as ursodeoxycholic acidHow we know
- Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary CirrhosisCompletedPhase 3Beijing Friendship HospitalNCT01857284Written as Ursodeoxycholic Acid CapsulesHow we know
- Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary CirrhosisStatus unknownPhase 1Robert Chunhua Zhao, MD, PhDNCT01440309Written as ursodeoxycholic acidHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting1
Results posted1
- Ursodeoxycholic Acid vs Metformin in Gestational Diabetes MellitusOct 28, 2026NCT04407650
Stopped1
- Ursodeoxycholic Acid vs Metformin in Gestational Diabetes MellitusTerminatedOct 28, 2026NCT04407650
Codes
What other systems call Ursodeoxycholic Acid · ClinicalTrials.gg INT008389
- MeSH (NLM) D014580Ursodeoxycholic AcidConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 724L30Y2QRURSODIOLConfirmed FDA, NLM
- RxNorm 11065One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014580 | Ursodeoxycholic Acid | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 724L30Y2QR | URSODIOL | Confirmed FDA, NLM |
| RxNorm | 11065 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.